TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36335970

Group type: EXPERIMENTAL
Intervention: Active eradication (oral clarithromycin 500 mg, metronidazole 400 mg, and lansoprazole 30 mg, twice daily for 1 week)
Number of subjects: 5352

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 5352

Group type: EXPERIMENTAL
Intervention: Active eradication
Number of subjects: 5352
Study: 32290271

Group type: EXPERIMENTAL
Intervention: Whey protein isolate (WPI) 50g/daily for 12 weeks
Number of subjects: 99

Group type: COMPARATOR
Intervention: Iso-caloric carbohydrate (CHO) control for 12 weeks
Number of subjects: 99
Study: 36471449

Group type: EXPERIMENTAL
Intervention: Bazedoxifene plus conjugated estrogen
Number of subjects: 0
Study: 34697593

Group type: EXPERIMENTAL
Intervention: Gemigliptin 50 mg daily along with standard care for diabetes mellitus for 6 months
Number of subjects: 201

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 201
Study: 36073578

Group type: EXPERIMENTAL
Intervention: Suture fixation of the parietal peritoneum
Number of subjects: 14

Group type: COMPARATOR
Intervention: Tack fixation of the parietal peritoneum
Number of subjects: 14
Study: 34332741

Group type: EXPERIMENTAL
Intervention: Next Day Discharge (NDD) group (≤1 day hospital stay)
Number of subjects: 22035

Group type: COMPARATOR
Intervention: Non-Next Day Discharge (non-NDD) group (>1 day hospital stay)
Number of subjects: 22035
Study: 34098030

Group type: EXPERIMENTAL
Intervention: Weekly cisplatin (7 doses of 40 mg/m2)
Number of subjects: 189

Group type: COMPARATOR
Intervention: Cetuximab (loading dose of 400 mg/m2 followed by 7 weekly doses of 250 mg/m2)
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 189
Study: 33993779

Group type: EXPERIMENTAL
Intervention: Sexual Assault condition (SA)
Number of subjects: 782

Group type: COMPARATOR
Intervention: Health condition
Number of subjects: 782

Group type: COMPARATOR
Intervention: Crime condition
Number of subjects: 782

Group type: COMPARATOR
Intervention: Alcohol condition
Number of subjects: 782
Study: 33811818

Group type: COMPARATOR
Intervention: AGRI-NUT group
Number of subjects: 148

Group type: COMPARATOR
Intervention: AGRI-NUT+PLA group
Number of subjects: 148

Group type: COMPARATOR
Intervention: AGRI group
Number of subjects: 148
Study: 32650801

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) injection (8 mL)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Corticosteroid (CS) injection (1 mL of 40 mg/mL triamcinolone acetonide plus 5 mL of 2% lidocaine)
Number of subjects: 40
Study: 34971028

Group type: EXPERIMENTAL
Intervention: iSupport-Portugal
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control (e-book)
Number of subjects: 42
Study: 33627163

Group type: EXPERIMENTAL
Intervention: Spinal manipulation (four times over two weeks)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Spinal manipulation
Number of subjects: 132
Study: 36261132

Group type: EXPERIMENTAL
Intervention: LISA
Number of subjects: 42

Group type: COMPARATOR
Intervention: INSURE
Number of subjects: 42
Study: 33484151

Group type: EXPERIMENTAL
Intervention: SHHC intervention (n = 101)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Education-only control intervention (n = 93)
Number of subjects: 194
Study: 35657603

Group type: EXPERIMENTAL
Intervention: Computer-based Diagnostic Engine (CDE)
Number of subjects: 212
Study: 33479505

Group type: EXPERIMENTAL
Intervention: Informative and motivational video messages
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Small monetary incentives
Number of subjects: 0
Study: 33099944

Group type: COMPARATOR
Intervention: Chemotherapy (group A)
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Concurrent chemoradiotherapy (group B)
Number of subjects: 146
Study: 33242112

Group type: EXPERIMENTAL
Intervention: Facial nerve stimulation (FNS) group
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (without FNS)
Number of subjects: 29
Study: 34353042

Group type: EXPERIMENTAL
Intervention: Comprehensive nursing intervention combined with respiratory functional exercises
Number of subjects: 150

Group type: COMPARATOR
Intervention: Routine nursing (Control)
Number of subjects: 150
Study: 32076917

Group type: EXPERIMENTAL
Intervention: Sofosbuvir/Daclatasvir (SOF/DCV) therapy for 12 weeks
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Sofosbuvir/Daclatasvir (SOF/DCV) therapy
Number of subjects: 30
Study: 36018731

Group type: EXPERIMENTAL
Intervention: Interruptive electronic alerts for PSA testing
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (no alerts)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Interruptive electronic alerts for various tests
Number of subjects: 10
Study: 33866079

Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 0
Study: 34435831

Group type: EXPERIMENTAL
Intervention: Personalized normative feedback (PNF)
Number of subjects: 1188

Group type: COMPARATOR
Intervention: Control
Number of subjects: 1188
Study: 34010505

Group type: EXPERIMENTAL
Intervention: Learning through Play Plus (LTP+) added to treatment as usual (TAU)
Number of subjects: 774

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 774
Study: 32646509

Group type: EXPERIMENTAL
Intervention: Mental Health Care Package (MHCP) implemented in 10 health facilities
Number of subjects: 37

Group type: COMPARATOR
Intervention: Comparative control group (10 health facilities without MHCP)
Number of subjects: 37
Study: 34382931

Group type: EXPERIMENTAL
Intervention: Progressive exercise (n=174) (six or fewer physiotherapy sessions)
Number of subjects: 708

Group type: COMPARATOR
Intervention: Best-practice advice (n=174) (one physiotherapy session)
Number of subjects: 708

Group type: EXPERIMENTAL
Intervention: Corticosteroid injection then progressive exercise (n=182) (six or fewer physiotherapy sessions)
Number of subjects: 708

Group type: EXPERIMENTAL
Intervention: Corticosteroid injection then best-practice advice (n=178) (one physiotherapy session)
Number of subjects: 708
Study: 35862479

Group type: EXPERIMENTAL
Intervention: Eccentric resistance exercise
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 51
Study: 33104189

Group type: EXPERIMENTAL
Intervention: Rapid Intermittent Bolus (RIB) therapy of hypertonic saline, 3%, for 24 to 48 hours
Number of subjects: 178

Group type: COMPARATOR
Intervention: Slow Continuous Infusion (SCI) therapy of hypertonic saline, 3%, for 24 to 48 hours
Number of subjects: 178
Study: 33977839

Group type: EXPERIMENTAL
Intervention: RIPC A (once daily for 1 week)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: RIPC B (twice daily for 1 week)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: RIPC C (once daily for 4 weeks)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: RIPC D (twice daily for 4 weeks)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Control (no specific sham treatment)
Number of subjects: 250
Study: 33594821

Group type: EXPERIMENTAL
Intervention: Intermittent TKI treatment (1 month ON and 1 month OFF)
Number of subjects: 166
Study: 32803815

Group type: EXPERIMENTAL
Intervention: Managing Cancer and Living Meaningfully (CALM) therapy
Number of subjects: 206

Group type: COMPARATOR
Intervention: Non‐manualized supportive psycho‐oncological counselling intervention (SPI)
Number of subjects: 206
Study: 34414903

Group type: EXPERIMENTAL
Intervention: ivabradine (5 mg)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: metoprolol (25 mg)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: ivabradine (5 mg) and metoprolol (25 mg) combination
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 150
Study: 33351303

Group type: COMPARATOR
Intervention: Testosterone Undecanoate Capsules (TUC) 40 mg, bid
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Jiarong Tablets (JRT) + Testosterone Undecanoate Capsules (TUC) 0.92 g, tid
Number of subjects: 200
Study: 35927649

Group type: EXPERIMENTAL
Intervention: Feedback reports providing information about routine data-based quality indicators (QIs) for gonarthrosis and/or coxarthrosis patients.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Facilitated network meetings for physicians.
Number of subjects: 0
Study: 32539487

Group type: EXPERIMENTAL
Intervention: Cognition test battery administered with a test-retest interval of ≥10 days
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Cognition test battery administered with a test-retest interval of ≤5 days
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Cognition test battery administered 4 times per day
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Cognition test battery with test-retest interval affecting practice effects
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Cognition test battery with unique stimulus sets
Number of subjects: 46
Study: 34148927

Group type: EXPERIMENTAL
Intervention: myBeat device (n=150)
Number of subjects: 300

Group type: COMPARATOR
Intervention: 24‐h Holter monitoring (control group; n=150)
Number of subjects: 300
Study: 32889859

Group type: EXPERIMENTAL
Intervention: Web-based system supporting vestibulo-ocular reflex with oculomotor and optokinetic stimulus
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional vestibular rehabilitation
Number of subjects: 20
Study: 36117554

Group type: EXPERIMENTAL
Intervention: US-guided caudal block (Group C)
Number of subjects: 0

Group type: COMPARATOR
Intervention: US-guided femoral and sciatic nerve blocks (Group P)
Number of subjects: 0
Study: 32212237

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 1200 mg TID (3600 mg/day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (0 mg TID)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Larger money alternative ($1.50)
Number of subjects: 12
Study: 36493691

Group type: EXPERIMENTAL
Intervention: Bilateral Electroconvulsive Therapy (ECT)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Antidepressant treatment (Control)
Number of subjects: 35
Study: 34238608

Group type: EXPERIMENTAL
Intervention: MTBVAC
Number of subjects: 0

Group type: COMPARATOR
Intervention: BCG
Number of subjects: 0
Study: 32466473

Group type: COMPARATOR
Intervention: Thigh cuffs (potential countermeasure)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Dry immersion (DI)
Number of subjects: 18
Study: 34040199

Group type: EXPERIMENTAL
Intervention: 5:2 intermittent energy restriction (IER)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Continuous energy restriction (CER)
Number of subjects: 16
Study: 33245525

Group type: EXPERIMENTAL
Intervention: Dental treatment in the presence of a therapy dog
Number of subjects: 102

Group type: COMPARATOR
Intervention: Regular dental setup (control group)
Number of subjects: 102
Study: 35782811

Group type: EXPERIMENTAL
Intervention: MRM with axillary lymphatic vessel ligation and quilting
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional modified radical mastectomy (MRM)
Number of subjects: 120
Study: 32273943

Group type: EXPERIMENTAL
Intervention: Fasting
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SET8 overexpression
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PGC1α overexpression
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: In vivo experiments
Number of subjects: 0
Study: 34904238

Group type: EXPERIMENTAL
Intervention: Collaborative care
Number of subjects: 200
Study: 33007710

Group type: EXPERIMENTAL
Intervention: High Intensity Interval Training (HIIT)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Lower Intensity Training (LIT)
Number of subjects: 33
Study: 35950596

Group type: EXPERIMENTAL
Intervention: Group exercise intervention (twice a week for eight weeks)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 40
Study: 33883862

Group type: EXPERIMENTAL
Intervention: Combined education and skills intervention
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Knowledge only intervention
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Behavioral skills only intervention
Number of subjects: 255

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 255
Study: 34435439

Group type: EXPERIMENTAL
Intervention: Sugammadex 0.56 mg/kg
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Neostigmine (doses of 10, 25, 40, 55, or 70 μg/kg)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Sugammadex (doses of 0.125, 0.25, 0.5, 1.0, or 2.0 mg/kg)
Number of subjects: 121
Study: 33052757

Group type: EXPERIMENTAL
Intervention: Cisplatin (40 mg/m2 weekly during RT)
Number of subjects: 298

Group type: COMPARATOR
Intervention: Cetuximab (400 mg/m2 1 week before RT followed by 250 mg/m2/wk during RT)
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Dose escalation in T3‐T4 tumors
Number of subjects: 298
Study: 32343035

Group type: EXPERIMENTAL
Intervention: Lumbar segmental stabilization exercises
Number of subjects: 26

Group type: COMPARATOR
Intervention: General exercises
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Comparison between groups
Number of subjects: 26
Study: 35841521

Group type: EXPERIMENTAL
Intervention: Same-day PEG (2 L between 5:00 AM and 7:00 AM)
Number of subjects: 384

Group type: COMPARATOR
Intervention: Split-dose PEG (1 L between 6:00 PM and 7:00 PM the day before and 1 L between 6:00 AM and 7:00 AM on the day of colonoscopy)
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: Same-day PEG
Number of subjects: 384

Group type: COMPARATOR
Intervention: Split-dose PEG
Number of subjects: 384
Study: 33419917

Group type: EXPERIMENTAL
Intervention: Water-sensitive intervention involving site-specific, modular, decentralised infrastructure to improve health by decreasing exposure to environmental faecal contamination.
Number of subjects: 144

Group type: COMPARATOR
Intervention: Control group receiving no intervention initially, but will be offered intervention delivery after trial completion.
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Water-sensitive intervention
Number of subjects: 144
Study: 34328539

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (3,000 IU per day)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 135
Study: 34050603

Group type: EXPERIMENTAL
Intervention: Enhanced access to the Cochrane Handbook recommendations
Number of subjects: 2271

Group type: COMPARATOR
Intervention: General link to the Cochrane Handbook (Control)
Number of subjects: 2271
Study: 33176094

Group type: EXPERIMENTAL
Intervention: Early combination (vildagliptin+metformin)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Metformin monotherapy
Number of subjects: 39
Study: 32053144

Group type: EXPERIMENTAL
Intervention: Mesenchymal stem cell (MSC) therapy via transendocardial injections
Number of subjects: 34
Study: 34229896

Group type: EXPERIMENTAL
Intervention: Standard of care plus melatonin at a dose of 3 mg three times daily for 14 days
Number of subjects: 74

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 74
Study: 32312225

Group type: EXPERIMENTAL
Intervention: Flexible tip bougie
Number of subjects: 32

Group type: COMPARATOR
Intervention: Standard bougie
Number of subjects: 32
Study: 33356686

Group type: EXPERIMENTAL
Intervention: Stepwise dose reduction (DR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 0
Study: 34802917

Group type: EXPERIMENTAL
Intervention: Physical activity and fall prevention intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy eating intervention
Number of subjects: 0
Study: 35248094

Group type: EXPERIMENTAL
Intervention: Yoga-based intervention package (slow breathing, Surya-namaskaram, mindfulness meditation)
Number of subjects: 584

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 584
Study: 32215805

Group type: EXPERIMENTAL
Intervention: Apatinib mesylate 500–750 mg
Number of subjects: 105
Study: 32660857

Group type: EXPERIMENTAL
Intervention: Online access to the educative platform (group B)
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Demonstration of the platform and online access (group C)
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Demonstration of the platform before using it (group C)
Number of subjects: 244

Group type: COMPARATOR
Intervention: Traditional clinical training (group A)
Number of subjects: 244
Study: 36316706

Group type: EXPERIMENTAL
Intervention: Logo-therapy intervention (4 sessions of 45-60 min, three times a week)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Logo-therapy intervention
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no logo-therapy intervention)
Number of subjects: 80
Study: 33912402

Group type: EXPERIMENTAL
Intervention: Cognitive reappraisal (CR)
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Self-compassion (SC)
Number of subjects: 265

Group type: COMPARATOR
Intervention: Wait-list control (WLC)
Number of subjects: 265
Study: 36016767

Group type: EXPERIMENTAL
Intervention: Oral N-acetyl cysteine
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 32294257

Group type: EXPERIMENTAL
Intervention: Watershared incentive-based conservation program
Number of subjects: 129

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 129
Study: 35862138

Group type: EXPERIMENTAL
Intervention: ILR screening
Number of subjects: 5997

Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 5997
Study: 32216490

Group type: EXPERIMENTAL
Intervention: 400 mg daily vaginal progesterone
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study: 32493502

Group type: EXPERIMENTAL
Intervention: Healthy behavior text messaging (daily)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Blood pressure self‐monitoring (daily)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Facilitated primary care provider appointment scheduling (yes)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy behavior text messaging (none)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Blood pressure self‐monitoring (weekly)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Facilitated primary care provider appointment scheduling (no)
Number of subjects: 0
Study: 36002117

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA) 5000 mg orally once daily from D 120 until parturition
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA) 5000 mg orally twice daily from D 285 until parturition
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group received 5000 mg lactose orally once daily from D 120 until parturition
Number of subjects: 16
Study: 33103201

Group type: EXPERIMENTAL
Intervention: Videos providing education about aging, ageism, and positive intergenerational contact
Number of subjects: 845

Group type: COMPARATOR
Intervention: Education about wallpaper
Number of subjects: 845
Study: 32044820

Group type: EXPERIMENTAL
Intervention: Spironolactone 100 mg
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Eplerenone 100 mg
Number of subjects: 105

Group type: COMPARATOR
Intervention: Eplerenone 50 mg
Number of subjects: 105
Study: 36291258

Group type: EXPERIMENTAL
Intervention: Cerebellar anodal tDCS
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Cerebellar anodal and cathodal tDCS
Number of subjects: 174
Study: 32524895

Group type: EXPERIMENTAL
Intervention: Standard Helping-Babies-Breathe training with video-debriefing
Number of subjects: 86

Group type: COMPARATOR
Intervention: Standard Helping-Babies-Breathe training
Number of subjects: 86
Study: 32780594

Group type: EXPERIMENTAL
Intervention: Immediate Intervention (II; n = 40)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Delayed Intervention Control (DI; n = 42)
Number of subjects: 82
Study: 36013495

Group type: EXPERIMENTAL
Intervention: Intra-articular single platelet-rich plasma (PRP)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Novel crosslinked hyaluronic acid (HA)
Number of subjects: 110
Study: 33165057

Group type: EXPERIMENTAL
Intervention: AbobotulinumtoxinA (ABO) 50 U
Number of subjects: 120
Study: 32106558

Group type: COMPARATOR
Intervention: Control group (Basic messages)
Number of subjects: 2115

Group type: EXPERIMENTAL
Intervention: Care-Seeking (CS) message group
Number of subjects: 2115

Group type: EXPERIMENTAL
Intervention: Good Household Prenatal Practices (GHPP) message group
Number of subjects: 2115

Group type: EXPERIMENTAL
Intervention: All Texts group
Number of subjects: 2115

Group type: EXPERIMENTAL
Intervention: Care-Seeking message group
Number of subjects: 2115
Study: 33765856

Group type: EXPERIMENTAL
Intervention: 5/0 polyester Ethibond (group A)
Number of subjects: 42

Group type: COMPARATOR
Intervention: 5/0 Coated Vicryl® (polyglactin 910) (group B)
Number of subjects: 42
Study: 33514479

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) intervention, 5 sessions
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) intervention
Number of subjects: 41
Study: 35596166

Group type: EXPERIMENTAL
Intervention: Computer-controlled Intraligamentary anaesthesia (CC-ILA)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Inferior alveolar nerve block (IANB)
Number of subjects: 50
Study: 33234777

Group type: EXPERIMENTAL
Intervention: Supraglottic jet oxygenation and ventilation (SJOV) using Wei nasal jet tube (WNJ)
Number of subjects: 280

Group type: COMPARATOR
Intervention: Nasal cannula oxygenation (NCO)
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Supraglottic jet oxygenation and ventilation (SJOV)
Number of subjects: 280
Study: 34907594

Group type: EXPERIMENTAL
Intervention: 0.1 mg/kg Remimazolam Tosilate (R1)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: 0.2 mg/kg Remimazolam Tosilate (R2)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Propofol (P)
Number of subjects: 99
Study: 33940380

Group type: EXPERIMENTAL
Intervention: Tympanostomy tube placement at or before 8 weeks of age
Number of subjects: 22
Study: 35766053

Group type: EXPERIMENTAL
Intervention: 0.1875% ropivacaine
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 0.25% ropivacaine
Number of subjects: 50
Study: 33685850

Group type: EXPERIMENTAL
Intervention: Glucosamine, chondroitin sulfate, and methylsulfonylmethane (GCM) supplementation after arthrocentesis plus intraarticular hyaluronic acid (HA) injection
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group: Arthrocentesis plus intraarticular HA injection only
Number of subjects: 26
Study: 33980536

Group type: EXPERIMENTAL
Intervention: Community follow-up by non-medical practitioners
Number of subjects: 742

Group type: COMPARATOR
Intervention: Hospital-based secondary care
Number of subjects: 742